241 related articles for article (PubMed ID: 16502042)
21. Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk.
Ming-Shiean H; Yu JC; Wang HW; Chen ST; Hsiung CN; Ding SL; Wu PE; Shen CY; Cheng CW
Ann Surg Oncol; 2010 Mar; 17(3):760-71. PubMed ID: 20183911
[TBL] [Abstract][Full Text] [Related]
22. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.
Ruiz-Narváez EA; Haddad SA; Lunetta KL; Yao S; Bensen JT; Sucheston-Campbell LE; Hong CC; Haiman CA; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2016 Jan; 155(2):355-63. PubMed ID: 26743380
[TBL] [Abstract][Full Text] [Related]
23. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study.
Hsiao WC; Young KC; Lin SL; Lin PW
Breast Cancer Res; 2004; 6(3):R180-6. PubMed ID: 15084241
[TBL] [Abstract][Full Text] [Related]
26. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.
Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY
Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092
[TBL] [Abstract][Full Text] [Related]
27. Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.
Hannafon BN; Gin AL; Xu YF; Bruns M; Calloway CL; Ding WQ
Cell Commun Signal; 2019 Feb; 17(1):13. PubMed ID: 30782165
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
29. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
30. Hormone-related pathways and risk of breast cancer subtypes in African American women.
Haddad SA; Lunetta KL; Ruiz-Narváez EA; Bensen JT; Hong CC; Sucheston-Campbell LE; Yao S; Bandera EV; Rosenberg L; Haiman CA; Troester MA; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2015 Nov; 154(1):145-54. PubMed ID: 26458823
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.
Mazumdar A; Wang RA; Mishra SK; Adam L; Bagheri-Yarmand R; Mandal M; Vadlamudi RK; Kumar R
Nat Cell Biol; 2001 Jan; 3(1):30-7. PubMed ID: 11146623
[TBL] [Abstract][Full Text] [Related]
32. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer.
Fearon ER
Cancer Cell; 2003 Apr; 3(4):307-10. PubMed ID: 12726856
[TBL] [Abstract][Full Text] [Related]
33. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
Talukder AH; Gururaj A; Mishra SK; Vadlamudi RK; Kumar R
Mol Cell Biol; 2004 Aug; 24(15):6581-91. PubMed ID: 15254226
[TBL] [Abstract][Full Text] [Related]
34. Expression of the human MTA1 gene in breast cell lines and in breast cancer tissues.
Tong D; Heinze G; Schremmer M; Schuster E; Czerwenka K; Leodolter S; Zeillinger R
Oncol Res; 2007; 16(10):465-70. PubMed ID: 18196870
[TBL] [Abstract][Full Text] [Related]
35. Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk.
Han W; Kang D; Lee KM; Kim HJ; Ahn SJ; Kim SW; Chung KW; Lee ES; Noh DY
Anticancer Res; 2003; 23(6C):4703-7. PubMed ID: 14981916
[TBL] [Abstract][Full Text] [Related]
36. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
Tan R; Wang L; Song J; Li J; He T
J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
[TBL] [Abstract][Full Text] [Related]
37. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
38. Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.
Zhang J; Yao S; Hu Q; Zhu Q; Liu S; Lunetta KL; Haddad SA; Yang N; Shen H; Hong CC; Sucheston-Campbell L; Ruiz-Narvaez EA; Bensen JT; Troester MA; Bandera EV; Rosenberg L; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Carcinogenesis; 2016 Oct; 37(10):951-956. PubMed ID: 27485598
[TBL] [Abstract][Full Text] [Related]
39. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
40. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
